Sentinext Therapeutics SDN BHD Submits United States Patent Application for Antigens and Vaccines Directed Against Human Enteroviruses

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Global IP News (India), May 22, 2015 Biotechnology Patent News, 2pp
  • Additional Information
    • Abstract:
      Alexandria, May 22 -- Sentinext Therapeutics SDN BHD has submitted a patent application for antigens and vaccines directed against human enteroviruses. This invention was developed by Cardosa Mary Jane, Jamiluddin Mohamad Fakruddin and Hamid Sharifah Binti. The patent application number is 14/402495. International Patent Classification codes are A61K 39/125 20060101 A61K039/125 and C12N 7/00 20060101 C12N007/00...